Imodium (Loperamide Hydrochloride)

Loperamide hydrochloride acts as a peripheral μ‑opioid receptor agonist in the intestinal wall. By binding these receptors, it inhibits the release of acetylcholine and other neurotransmitters, decreasing smooth‑muscle activity, prolonging transit time, and increasing fluid absorption, which results in firmer, less frequent stools.

The appropriate dose of Imodium is determined by a prescriber based on the patient’s age, condition severity, and response to therapy. Healthcare professionals tailor the regimen to each individual, and patients should follow the specific instructions provided by their clinician.

Safety of Imodium in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using the product.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imodium (loperamide) is a peripherally acting opioid agonist, whereas other antidiarrheals like diphenoxylate‑atropine combine opioid activity with anticholinergic effects. Loperamide generally has fewer central nervous system effects and is available over‑the‑counter, making it a common first‑line choice for many diarrheal conditions.

Imodium should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Imodium is taken orally, usually in tablet form, with or without water. The exact method of administration, including whether to take it with food, should follow the prescriber’s directions and the product labeling.

Serious risks include severe constipation that can lead to bowel obstruction, toxic megacolon in susceptible individuals, and rare cardiac arrhythmias such as QT prolongation when taken in high doses or combined with interacting drugs.

Imodium should be avoided in patients with known hypersensitivity to loperamide, those with bacterial or parasitic infections causing diarrhea, individuals with severe liver impairment, and very young children unless specifically prescribed by a pediatric specialist.